메뉴 건너뛰기




Volumn 46, Issue 5, 2010, Pages 369-372

TGFβ1 genetic polymorphism is associated with survival in head and neck squamous cell carcinoma independent of the severity of chemoradiotherapy induced mucositis

Author keywords

Chemotherapy; Complications; Head and neck cancer; Mucous membrane; Neoplasm; Radiotherapy; Survival; Transforming growth factor beta

Indexed keywords

CARBOPLATIN; CISPLATIN; DNA; GEFITINIB; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77950860609     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.02.012     Document Type: Article
Times cited : (17)

References (21)
  • 2
    • 0033780559 scopus 로고    scopus 로고
    • Prevention and management of mucositis in patients with cancer
    • Herrstedt J. Prevention and management of mucositis in patients with cancer. Int J Antimicrob Agents 16 2 (2000) 161-163
    • (2000) Int J Antimicrob Agents , vol.16 , Issue.2 , pp. 161-163
    • Herrstedt, J.1
  • 4
    • 0038399940 scopus 로고    scopus 로고
    • Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
    • Trotti A., Bellm L.A., Epstein J.B., Frame D., Fuchs H.J., Gwede C.K., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66 3 (2003) 253-262
    • (2003) Radiother Oncol , vol.66 , Issue.3 , pp. 253-262
    • Trotti, A.1    Bellm, L.A.2    Epstein, J.B.3    Frame, D.4    Fuchs, H.J.5    Gwede, C.K.6
  • 6
    • 0034177228 scopus 로고    scopus 로고
    • Toxicity in head and neck cancer: a review of trends and issues
    • Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47 1 (2000) 1-12
    • (2000) Int J Radiat Oncol Biol Phys , vol.47 , Issue.1 , pp. 1-12
    • Trotti, A.1
  • 8
    • 0034604110 scopus 로고    scopus 로고
    • Role of transforming growth factor beta in human disease
    • Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 342 18 (2000) 1350-1358
    • (2000) N Engl J Med , vol.342 , Issue.18 , pp. 1350-1358
    • Blobe, G.C.1    Schiemann, W.P.2    Lodish, H.F.3
  • 9
    • 2542617126 scopus 로고    scopus 로고
    • Medical applications of transforming growth factor-beta
    • Flanders K.C., and Burmester J.K. Medical applications of transforming growth factor-beta. Clin Med Res 1 1 (2003) 13-20
    • (2003) Clin Med Res , vol.1 , Issue.1 , pp. 13-20
    • Flanders, K.C.1    Burmester, J.K.2
  • 10
    • 0030907791 scopus 로고    scopus 로고
    • Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis
    • Sonis S.T., Van Vugt A.G., Brien J.P., Muska A.D., Bruskin A.M., Rose A., et al. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncol 33 1 (1997) 47-54
    • (1997) Oral Oncol , vol.33 , Issue.1 , pp. 47-54
    • Sonis, S.T.1    Van Vugt, A.G.2    Brien, J.P.3    Muska, A.D.4    Bruskin, A.M.5    Rose, A.6
  • 11
    • 0033052122 scopus 로고    scopus 로고
    • Phase I study of transforming growth factor-beta 3 mouthwashes for prevention of chemotherapy-induced mucositis
    • Wymenga A.N., van der Graaf W.T., Hofstra L.S., Spijkervet F.K., Timens W., Timmer-Bosscha H., et al. Phase I study of transforming growth factor-beta 3 mouthwashes for prevention of chemotherapy-induced mucositis. Clin Cancer Res 5 6 (1999) 1363-1368
    • (1999) Clin Cancer Res , vol.5 , Issue.6 , pp. 1363-1368
    • Wymenga, A.N.1    van der Graaf, W.T.2    Hofstra, L.S.3    Spijkervet, F.K.4    Timens, W.5    Timmer-Bosscha, H.6
  • 12
    • 17944368738 scopus 로고    scopus 로고
    • Investigators in TGF/OM study protocols. Topical transforming growth factor-[beta]3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors
    • Foncuberta M.C., Cagnoni P.J., Brandts C.H., Mandanas R., Fields K., Derigs H.G., et al. Investigators in TGF/OM study protocols. Topical transforming growth factor-[beta]3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors. J Immunother 24 4 (2001) 384-388
    • (2001) J Immunother , vol.24 , Issue.4 , pp. 384-388
    • Foncuberta, M.C.1    Cagnoni, P.J.2    Brandts, C.H.3    Mandanas, R.4    Fields, K.5    Derigs, H.G.6
  • 13
    • 0036648451 scopus 로고    scopus 로고
    • Transforming growth factor-beta 2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling
    • van't Land B., Meijer H.P., Frerichs J., Koetsier M., Jager D., Smeets R.L., et al. Transforming growth factor-beta 2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. Br J Cancer 87 1 (2002) 113-118
    • (2002) Br J Cancer , vol.87 , Issue.1 , pp. 113-118
    • van't Land, B.1    Meijer, H.P.2    Frerichs, J.3    Koetsier, M.4    Jager, D.5    Smeets, R.L.6
  • 14
    • 30344460526 scopus 로고    scopus 로고
    • Nutritional supplementation with transforming growth factor-[beta], glutamine, and short chain fatty acids minimizes methotrexate-induced injury
    • Harsha W.T.F., Kalandarova E., McNutt P., Irwin R., and Noel J. Nutritional supplementation with transforming growth factor-[beta], glutamine, and short chain fatty acids minimizes methotrexate-induced injury. J Pediatr Gastroenterol Nutr 42 1 (2006) 53-58
    • (2006) J Pediatr Gastroenterol Nutr , vol.42 , Issue.1 , pp. 53-58
    • Harsha, W.T.F.1    Kalandarova, E.2    McNutt, P.3    Irwin, R.4    Noel, J.5
  • 15
    • 0038519761 scopus 로고    scopus 로고
    • A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer
    • Dunning A.M., Ellis P.D., McBride S., Kirschenlohr H.L., Healey C.S., Kemp P.R., et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63 10 (2003) 2610-2615
    • (2003) Cancer Res , vol.63 , Issue.10 , pp. 2610-2615
    • Dunning, A.M.1    Ellis, P.D.2    McBride, S.3    Kirschenlohr, H.L.4    Healey, C.S.5    Kemp, P.R.6
  • 16
    • 66349109789 scopus 로고    scopus 로고
    • Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer
    • Lundberg M., Pajusto M., Koskinen W.J., Makitie A.A., Aaltonen L.M., and Mattila P.S. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer. Head Neck 31 5 (2009) 664-672
    • (2009) Head Neck , vol.31 , Issue.5 , pp. 664-672
    • Lundberg, M.1    Pajusto, M.2    Koskinen, W.J.3    Makitie, A.A.4    Aaltonen, L.M.5    Mattila, P.S.6
  • 17
    • 0028969271 scopus 로고
    • Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)
    • Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31 5 (1995) 1341-1346
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , Issue.5 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 18
    • 1942469964 scopus 로고    scopus 로고
    • The pathobiology of mucositis
    • Sonis S.T. The pathobiology of mucositis. Nat Rev Cancer 4 4 (2004) 277-284
    • (2004) Nat Rev Cancer , vol.4 , Issue.4 , pp. 277-284
    • Sonis, S.T.1
  • 19
    • 0026636951 scopus 로고
    • Loss of local control with prolongation in radiotherapy
    • Fowler J.F., and Lindstrom M.J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23 2 (1992) 457-467
    • (1992) Int J Radiat Oncol Biol Phys , vol.23 , Issue.2 , pp. 457-467
    • Fowler, J.F.1    Lindstrom, M.J.2
  • 20
    • 20444435582 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy in the treatment of head and neck cancer
    • Eisbruch A. Intensity-modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2 1 (2005) 34-39
    • (2005) Nat Clin Pract Oncol , vol.2 , Issue.1 , pp. 34-39
    • Eisbruch, A.1
  • 21
    • 14844337004 scopus 로고    scopus 로고
    • Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function
    • Saarilahti K., Kouri M., Collan J., Hamalainen T., Atula T., Joensuu H., et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74 3 (2005) 251-258
    • (2005) Radiother Oncol , vol.74 , Issue.3 , pp. 251-258
    • Saarilahti, K.1    Kouri, M.2    Collan, J.3    Hamalainen, T.4    Atula, T.5    Joensuu, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.